Number of individuals: 36
Significantly mutated genes (q≤0.1) | 7 |
Mutations seen in COSMIC | 0 |
Significantly mutated genes on COSMIC territory | 0 |
Genes with clustered mutations (≤3 aa apart) | 0 |
Significantly mutated genesets | 67 |
. . . . . . . . . (excluding sig.mutated genes) | 19 |
Read 36 MAFs of type "Broad"
Total number of mutations in input MAFs: 10009
After removing 2687 noncoding mutations: 7322
After collapsing adjacent/redundant mutations: 7307
Please see MutSigPreprocess "stdout.txt" for full details.
Number of mutations before filtering: 7307
After removing 57 mutations outside gene set: 7250
After removing 2049 mutations outside category set: 5201
Please see MutSigRun "stdout.txt" for full details.
Final set of mutations used in analysis
type | count |
---|---|
Frame_Shift_Del | 20 |
Frame_Shift_Ins | 17 |
In_Frame_Del | 9 |
In_Frame_Ins | 1 |
Missense_Mutation | 3422 |
Nonsense_Mutation | 330 |
Nonstop_Mutation | 7 |
Silent | 1335 |
Splice_Site | 60 |
Total | 5201 |
category | n | N | rate | rate_per_mb | relative_rate |
---|---|---|---|---|---|
(A/T)p*A->T | 381 | 212,530,608 | 1.79e-06 | 1.79 | 0.51 |
(A/T)p*N->nonflip | 1231 | 472,118,544 | 2.61e-06 | 2.61 | 0.74 |
(C/G)p*N->mut | 1582 | 623,521,188 | 2.54e-06 | 2.54 | 0.72 |
(A/T)p*C->G | 228 | 259,587,936 | 8.78e-07 | 0.88 | 0.25 |
indel+null | 438 | 1,095,639,768 | 4.00e-07 | 0.40 | 0.11 |
double_null | 6 | 1,095,639,768 | 5.48e-09 | 0.0055 | 0.0016 |
Total | 3866 | 1,095,639,768 | 3.53e-06 | 3.53 | 1.00 |
rank | gene | description | N | n | npat | nsite | nsil | n1 | n2 | n3 | n4 | n5 | n6 | p | q |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 118332 | 9 | 7 | 3 | 0 | 5 | 0 | 4 | 0 | 0 | 0 | 5.45e-08 | 0.00098 |
2 | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 | 64404 | 5 | 5 | 4 | 0 | 0 | 3 | 1 | 1 | 0 | 0 | 1.89e-06 | 0.014 |
3 | MLL3 | myeloid/lymphoid or mixed-lineage leukemia 3 | 533196 | 8 | 7 | 8 | 2 | 0 | 1 | 1 | 0 | 4 | 2 | 2.27e-06 | 0.014 |
4 | POU4F1 | POU class 4 homeobox 1 | 27144 | 3 | 3 | 2 | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 3.09e-06 | 0.014 |
5 | OR5H6 | olfactory receptor, family 5, subfamily H, member 6 | 35352 | 3 | 3 | 3 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0.000023 | 0.074 |
6 | AQP2 | aquaporin 2 (collecting duct) | 29376 | 3 | 3 | 3 | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 0.000024 | 0.074 |
7 | FCRL1 | Fc receptor-like 1 | 48024 | 3 | 3 | 3 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 0.000038 | 0.098 |
8 | TMEM51 | transmembrane protein 51 | 27720 | 3 | 3 | 3 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 0.000072 | 0.15 |
9 | COL11A2 | collagen, type XI, alpha 2 | 182880 | 4 | 4 | 4 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0.000080 | 0.15 |
10 | DNAJB1 | DnaJ (Hsp40) homolog, subfamily B, member 1 | 37260 | 4 | 3 | 4 | 0 | 0 | 2 | 1 | 0 | 1 | 0 | 0.000084 | 0.15 |
11 | CDK11B | 53604 | 3 | 3 | 3 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0.000092 | 0.15 | |
12 | NFYB | nuclear transcription factor Y, beta | 23472 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0.00011 | 0.16 |
13 | SIGLEC10 | sialic acid binding Ig-like lectin 10 | 76968 | 3 | 3 | 3 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0.00012 | 0.17 |
14 | MAPK1 | mitogen-activated protein kinase 1 | 35712 | 3 | 3 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0.00017 | 0.21 |
15 | C15orf56 | chromosome 15 open reading frame 56 | 5292 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0.00017 | 0.21 |
16 | ZIC3 | Zic family member 3 heterotaxy 1 (odd-paired homolog, Drosophila) | 37008 | 2 | 2 | 2 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0.00027 | 0.30 |
17 | SUMO1 | SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae) | 11736 | 2 | 2 | 2 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0.00029 | 0.30 |
18 | DALRD3 | DALR anticodon binding domain containing 3 | 52776 | 3 | 2 | 3 | 1 | 0 | 0 | 2 | 1 | 0 | 0 | 0.00030 | 0.30 |
19 | MYH9 | myosin, heavy chain 9, non-muscle | 217548 | 5 | 4 | 5 | 1 | 0 | 1 | 2 | 0 | 2 | 0 | 0.00033 | 0.30 |
20 | TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 118152 | 4 | 3 | 4 | 0 | 0 | 1 | 2 | 0 | 1 | 0 | 0.00034 | 0.30 |
21 | HSD17B4 | hydroxysteroid (17-beta) dehydrogenase 4 | 83052 | 3 | 3 | 3 | 2 | 0 | 2 | 0 | 0 | 1 | 0 | 0.00035 | 0.30 |
22 | PTPN13 | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) | 267084 | 5 | 5 | 5 | 1 | 0 | 1 | 3 | 1 | 0 | 0 | 0.00039 | 0.32 |
23 | PTEN | phosphatase and tensin homolog (mutated in multiple advanced cancers 1) | 44928 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0.00043 | 0.33 |
24 | B2M | beta-2-microglobulin | 13392 | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0.00044 | 0.33 |
25 | SPANXN5 | SPANX family, member N5 | 8172 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0.00045 | 0.33 |
26 | MTA2 | metastasis associated 1 family, member 2 | 74844 | 2 | 2 | 2 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0.00049 | 0.34 |
27 | B3GNT8 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 | 43128 | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0.00051 | 0.34 |
28 | PRRG1 | proline rich Gla (G-carboxyglutamic acid) 1 | 24084 | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0.00056 | 0.35 |
29 | ARHGAP6 | Rho GTPase activating protein 6 | 89496 | 3 | 3 | 3 | 1 | 0 | 2 | 1 | 0 | 0 | 0 | 0.00056 | 0.35 |
30 | MUC17 | mucin 17, cell surface associated | 487224 | 6 | 6 | 6 | 2 | 0 | 1 | 4 | 0 | 1 | 0 | 0.00059 | 0.35 |
Notes
N = number of sequenced bases in this gene across the individual set
n = number of (nonsilent) mutations in this gene across the individual set
npat = number of patients (individuals) with at least one nonsilent mutation
nsite = number of unique sites having a nonsilent mutation
nsil = number of silent mutations in this gene across the individual set
n1 = number of nonsilent mutations of type "(A/T)p*A->T"
n2 = number of nonsilent mutations of type "(A/T)p*N->nonflip"
n3 = number of nonsilent mutations of type "(C/G)p*N->mut"
n4 = number of nonsilent mutations of type "(A/T)p*C->G"
n5 = number of nonsilent mutations of type "indel+null"
n6 = number of nonsilent mutations of type "double_null"
null = mutation category that includes nonsense, frameshift, splice-site mutations
p_classic = p-value for the observed amount of nonsilent mutations being elevated in this gene
p_ns_s = p-value for the observed nonsilent/silent ratio being elevated in this gene
p_ks = p-value for clustering of mutations (Kolmogorov-Smirnoff test)
p_cons = p-value for enrichment of mutations at evolutionarily most-conserved sites in gene
p_joint = p-value for clustering + conservation
p = p-value (overall)
q = q-value, False Discovery Rate (Benjamini-Hochberg procedure)
gene1 | gene2 | p | q | relationship |
---|---|---|---|---|
PIK3CA | POU4F1 | 0.090 | 0.67 | none |
NFE2L2 | OR5H6 | 0.17 | 0.67 | none |
AQP2 | FCRL1 | 0.24 | 0.67 | none |
FCRL1 | OR5H6 | 0.24 | 0.67 | none |
OR5H6 | POU4F1 | 0.24 | 0.67 | none |
MLL3 | NFE2L2 | 0.24 | 0.67 | none |
NFE2L2 | PIK3CA | 0.32 | 0.67 | none |
FCRL1 | NFE2L2 | 0.37 | 0.67 | none |
NFE2L2 | POU4F1 | 0.37 | 0.67 | none |
MLL3 | OR5H6 | 0.49 | 0.67 | none |
MLL3 | POU4F1 | 0.49 | 0.67 | none |
AQP2 | MLL3 | 0.51 | 0.67 | none |
AQP2 | PIK3CA | 0.51 | 0.67 | none |
FCRL1 | MLL3 | 0.51 | 0.67 | none |
FCRL1 | PIK3CA | 0.51 | 0.67 | none |
OR5H6 | PIK3CA | 0.51 | 0.67 | none |
MLL3 | PIK3CA | 0.59 | 0.72 | none |
AQP2 | NFE2L2 | 0.63 | 0.73 | none |
AQP2 | OR5H6 | 0.76 | 0.76 | none |
AQP2 | POU4F1 | 0.76 | 0.76 | none |
FCRL1 | POU4F1 | 0.76 | 0.76 | none |
Notes
p = probability of obtaining the observed degree of correlation or anti-correlation
between the given pair of genes, calculated by performing many random permutations of the
gene labels on the mutations in the dataset, thereby controling for sample-specific
and gene-specific mutation rates.
q = q-value, False Discovery Rate (Benjamini-Hochberg procedure), correcting for the
multiple hypotheses (one hypothesis per pair of genes considered.)
Two distinct analyses are reported using the COSMIC database:
(COS1) COSMIC used as a filter to increase power by restricting the territory of each gene
(COS2) COSMIC used as a prior for the importance of a gene
rank | gene | description | n | cos | n_cos | N_cos | cos_ev | p | q |
---|
Notes
n = number of mutations in this gene in the individual set
cos = number of unique mutated sites in this gene in COSMIC
n_cos = overlap between n and cos
N_cos = number of individuals × cos
cos_ev = total evidence: number of reports in COSMIC for mutations seen in this gene
p = p-value for seeing the observed amount of overlap in this gene
q = q-value, False Discovery Rate (Benjamini-Hochberg procedure)
rank | gene | description | n | cos | n_cos | cos_ev |
---|
Notes
n = number of mutations in this gene in the individual set
cos = number of unique mutated sites in this gene in COSMIC
n_cos = overlap between n and cos
cos_ev = total evidence: number of reports in COSMIC for mutations seen in this gene
patient | chr | start | end | type | gene | Protein_Change | n_cos |
---|
rank | gene | desc | n | mindist | npairs3 | npairs12 |
---|---|---|---|---|---|---|
1 | FAT2 | FAT tumor suppressor homolog 2 (Drosophila) | 4 | 2465 | 0 | 0 |
2 | A2M | alpha-2-macroglobulin | 2 | Inf | 0 | 0 |
3 | AATF | apoptosis antagonizing transcription factor | 2 | Inf | 0 | 0 |
4 | ABCA10 | ATP-binding cassette, sub-family A (ABC1), member 10 | 2 | Inf | 0 | 0 |
5 | ABCA12 | ATP-binding cassette, sub-family A (ABC1), member 12 | 4 | Inf | 0 | 0 |
6 | ABCA8 | ATP-binding cassette, sub-family A (ABC1), member 8 | 2 | Inf | 0 | 0 |
7 | ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | 2 | Inf | 0 | 0 |
8 | ABCD4 | ATP-binding cassette, sub-family D (ALD), member 4 | 2 | Inf | 0 | 0 |
9 | ABR | active BCR-related gene | 2 | Inf | 0 | 0 |
10 | ACACB | acetyl-Coenzyme A carboxylase beta | 2 | Inf | 0 | 0 |
11 | ACAP1 | 3 | Inf | 0 | 0 | |
12 | ACAP2 | 2 | Inf | 0 | 0 | |
13 | ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 3 | Inf | 0 | 0 |
14 | ADAMTS16 | ADAM metallopeptidase with thrombospondin type 1 motif, 16 | 2 | Inf | 0 | 0 |
15 | ADAMTS20 | ADAM metallopeptidase with thrombospondin type 1 motif, 20 | 2 | Inf | 0 | 0 |
16 | ADCY10 | adenylate cyclase 10 (soluble) | 2 | Inf | 0 | 0 |
17 | ADCY9 | adenylate cyclase 9 | 2 | Inf | 0 | 0 |
18 | AGBL5 | ATP/GTP binding protein-like 5 | 4 | Inf | 0 | 0 |
19 | AHNAK2 | AHNAK nucleoprotein 2 | 5 | Inf | 0 | 0 |
20 | AK7 | adenylate kinase 7 | 2 | Inf | 0 | 0 |
21 | AKAP3 | A kinase (PRKA) anchor protein 3 | 2 | Inf | 0 | 0 |
22 | ALCAM | activated leukocyte cell adhesion molecule | 2 | Inf | 0 | 0 |
23 | ALPK2 | alpha-kinase 2 | 2 | Inf | 0 | 0 |
24 | ALS2 | amyotrophic lateral sclerosis 2 (juvenile) | 2 | Inf | 0 | 0 |
25 | ANAPC1 | anaphase promoting complex subunit 1 | 3 | Inf | 0 | 0 |
26 | ANK1 | ankyrin 1, erythrocytic | 3 | Inf | 0 | 0 |
27 | ANK3 | ankyrin 3, node of Ranvier (ankyrin G) | 2 | Inf | 0 | 0 |
28 | ANKRD26 | ankyrin repeat domain 26 | 2 | Inf | 0 | 0 |
29 | ANKRD30A | ankyrin repeat domain 30A | 2 | Inf | 0 | 0 |
30 | ANKS1A | ankyrin repeat and sterile alpha motif domain containing 1A | 2 | Inf | 0 | 0 |
Notes
n = number of mutations in this gene in the individual set
mindist = distance (in aa) between closest pair of mutations in this gene
npairs3 = how many pairs of mutations are within 3 aa of each other
npairs12 = how many pairs of mutations are within 12 aa of each other
rank | geneset | description | genes | N_genes | mut_tally | N | n | npat | nsite | nsil | n1 | n2 | n3 | n4 | n5 | n6 | p | q |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | HSA04510_FOCAL_ADHESION | Genes involved in focal adhesion | ACTB, ACTG1, ACTN1, ACTN2, ACTN3, ACTN4, AKT1, AKT2, AKT3, ARHGAP5, BAD, BCAR1, BCL2, BIRC2, BIRC3, BIRC4, BRAF, CAPN2, CAV1, CAV2, CAV3, CCND1, CCND2, CCND3, CDC42, CHAD, COL11A1, COL11A2, COL1A1, COL1A2, COL2A1, COL3A1, COL4A1, COL4A2, COL4A4, COL4A6, COL5A1, COL5A2, COL5A3, COL6A1, COL6A2, COL6A3, COL6A6, COMP, CRK, CRKL, CTNNB1, DIAPH1, DOCK1, EGF, EGFR, ELK1, ERBB2, FARP2, FIGF, FLNA, FLNB, FLNC, FLT1, FN1, FYN, GRB2, GRLF1, GSK3B, HGF, HRAS, IBSP, IGF1, IGF1R, ILK, ITGA1, ITGA10, ITGA11, ITGA2, ITGA2B, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8, ITGA9, ITGAV, ITGB1, ITGB3, ITGB4, ITGB5, ITGB6, ITGB7, ITGB8, JUN, KDR, LAMA1, LAMA2, LAMA3, LAMA4, LAMA5, LAMB1, LAMB2, LAMB3, LAMB4, LAMC1, LAMC2, LAMC3, LOC653852, MAP2K1, MAPK1, MAPK10, MAPK3, MAPK8, MAPK9, MET, MLCK, MRCL3, MRLC2, MYL2, MYL5, MYL7, MYL8P, MYL9, MYLC2PL, MYLK, MYLK2, MYLPF, PAK1, PAK2, PAK3, PAK4, PAK6, PAK7, PARVA, PARVB, PARVG, PDGFA, PDGFB, PDGFC, PDGFD, PDGFRA, PDGFRB, PDPK1, PGF, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R5, PIP5K1C, PPP1CA, PPP1CB, PPP1CC, PPP1R12A, PRKCA, PRKCB1, PRKCG, PTEN, PTK2, PXN, RAC1, RAC2, RAC3, RAF1, RAP1A, RAP1B, RAPGEF1, RELN, RHOA, ROCK1, ROCK2, SHC1, SHC2, SHC3, SHC4, SOS1, SOS2, SPP1, SRC, THBS1, THBS2, THBS3, THBS4, TLN1, TLN2, TNC, TNN, TNR, TNXB, VASP, VAV1, VAV2, VAV3, VCL, VEGFA, VEGFB, VEGFC, VTN, VWF, ZYX | 192 | ACTN1(1), ACTN3(1), ACTN4(1), AKT3(1), BRAF(1), COL11A2(4), COL1A2(2), COL3A1(1), COL4A1(1), COL5A1(1), COL5A3(2), COL6A3(2), COMP(1), EGFR(1), ERBB2(1), FLNA(2), FLNC(1), FN1(2), GRLF1(1), ITGA4(1), ITGA7(2), ITGA8(2), ITGAV(1), LAMA1(2), LAMA2(1), LAMA4(1), LAMA5(1), LAMB1(1), LAMB2(1), LAMB3(1), MAPK1(3), PAK2(1), PAK3(1), PDGFC(1), PIK3CA(9), PIK3CD(1), PIK3CG(1), PIK3R1(1), PPP1CB(1), PPP1R12A(3), PRKCA(1), PTEN(2), PTK2(1), RELN(2), RHOA(1), ROCK1(3), ROCK2(2), SOS1(1), SOS2(1), TNC(2), TNXB(2), VWF(1) | 20561688 | 82 | 30 | 74 | 18 | 7 | 27 | 32 | 3 | 13 | 0 | 3.97e-09 | 2.44e-06 |
2 | HSA04810_REGULATION_ OF_ACTIN_CYTOSKELETON | Genes involved in regulation of actin cytoskeleton | ABI2, ACTN1, ACTN2, ACTN3, ACTN4, APC, APC2, ARAF, ARHGEF1, ARHGEF12, ARHGEF4, ARHGEF6, ARHGEF7, ARPC1A, ARPC1B, ARPC2, ARPC3, ARPC4, ARPC5, ARPC5L, BAIAP2, BCAR1, BDKRB1, BDKRB2, BRAF, C3orf10, CD14, CDC42, CFL1, CFL2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CRK, CRKL, CSK, CYFIP1, CYFIP2, DIAPH1, DIAPH2, DIAPH3, DOCK1, EGF, EGFR, EZR, F2, F2R, FGD1, FGD3, FGF1, FGF10, FGF11, FGF12, FGF13, FGF14, FGF16, FGF17, FGF18, FGF19, FGF2, FGF20, FGF21, FGF22, FGF23, FGF3, FGF4, FGF5, FGF6, FGF7, FGF8, FGF9, FGFR1, FGFR2, FGFR3, FGFR4, FN1, GIT1, GNA12, GNA13, GNG12, GRLF1, GSN, HRAS, INS, IQGAP1, IQGAP2, IQGAP3, ITGA1, ITGA10, ITGA11, ITGA2, ITGA2B, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8, ITGA9, ITGAD, ITGAE, ITGAL, ITGAM, ITGAV, ITGAX, ITGB1, ITGB2, ITGB3, ITGB4, ITGB5, ITGB6, ITGB7, ITGB8, KRAS, LIMK1, LIMK2, LOC200025, LOC645126, LOC653888, MAP2K1, MAP2K2, MAPK1, MAPK3, MLCK, MOS, MRAS, MRCL3, MRLC2, MSN, MYH10, MYH14, MYH9, MYL2, MYL5, MYL7, MYL8P, MYL9, MYLC2PL, MYLK, MYLK2, MYLPF, NCKAP1, NCKAP1L, NRAS, PAK1, PAK2, PAK3, PAK4, PAK6, PAK7, PDGFA, PDGFB, PDGFRA, PDGFRB, PFN1, PFN2, PFN3, PFN4, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R5, PIP4K2A, PIP4K2B, PIP4K2C, PIP5K1A, PIP5K1B, PIP5K1C, PIP5K3, PPP1CA, PPP1CB, PPP1CC, PPP1R12A, PPP1R12B, PTK2, PXN, RAC1, RAC2, RAC3, RAF1, RDX, RHOA, ROCK1, ROCK2, RRAS, RRAS2, SCIN, SLC9A1, SOS1, SOS2, SSH1, SSH2, SSH3, TIAM1, TIAM2, TMSB4X, TMSB4Y, TMSL3, VAV1, VAV2, VAV3, VCL, WAS, WASF1, WASF2, WASL | 203 | ACTN1(1), ACTN3(1), ACTN4(1), APC(3), ARHGEF6(1), ARPC5(1), BRAF(1), CYFIP1(1), DIAPH3(2), EGFR(1), EZR(1), F2R(1), FGF17(1), FGF2(1), FGF9(1), FN1(2), GNA13(1), GRLF1(1), ITGA4(1), ITGA7(2), ITGA8(2), ITGAE(1), ITGAM(2), ITGAV(1), KRAS(1), LIMK1(1), MAPK1(3), MYH10(2), MYH14(2), MYH9(5), NCKAP1(1), NCKAP1L(1), PAK2(1), PAK3(1), PIK3CA(9), PIK3CD(1), PIK3CG(1), PIK3R1(1), PIP5K1A(1), PPP1CB(1), PPP1R12A(3), PTK2(1), RHOA(1), ROCK1(3), ROCK2(2), SLC9A1(2), SOS1(1), SOS2(1), SSH2(1), SSH3(1), TIAM1(1), WASF2(1) | 15386760 | 81 | 29 | 73 | 28 | 9 | 29 | 23 | 5 | 15 | 0 | 1.29e-07 | 0.000040 |
3 | HSA04320_DORSO_VENTRAL_ AXIS_FORMATION | Genes involved in dorso-ventral axis formation | BRAF, CPEB1, EGFR, ERBB2, ERBB4, ETS1, ETS2, ETV6, ETV7, FMN2, GRB2, KRAS, MAP2K1, MAPK1, MAPK3, NOTCH1, NOTCH2, NOTCH3, NOTCH4, PIWIL1, PIWIL2, PIWIL3, PIWIL4, RAF1, SOS1, SOS2, SPIRE1, SPIRE2 | 28 | BRAF(1), EGFR(1), ERBB2(1), FMN2(1), KRAS(1), MAPK1(3), NOTCH1(6), NOTCH2(2), NOTCH4(1), PIWIL1(2), PIWIL3(1), PIWIL4(2), SOS1(1), SOS2(1) | 2917044 | 24 | 17 | 22 | 3 | 2 | 8 | 8 | 1 | 5 | 0 | 0.000014 | 0.0024 |
4 | ST_INTEGRIN_SIGNALING_ PATHWAY | Integrins are transmembrane receptors that mediate cell growth, survival, and migration by binding to ligands in the extracellular matrix. | ABL1, ACK1, ACTN1, ACTR2, ACTR3, AKT1, AKT2, AKT3, ANGPTL2, ARHGEF6, ARHGEF7, BCAR1, BRAF, CAV1, CDC42, CDKN2A, CRK, CSE1L, DDEF1, DOCK1, EPHB2, FYN, GRAF, GRB2, GRB7, GRF2, GRLF1, ILK, ITGA1, ITGA10, ITGA11, ITGA2, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8, ITGA9, ITGB3BP, MAP2K4, MAP2K7, MAP3K11, MAPK1, MAPK10, MAPK8, MAPK8IP1, MAPK8IP2, MAPK8IP3, MAPK9, MRAS, MYLK, MYLK2, P4HB, PAK1, PAK2, PAK3, PAK4, PAK6, PAK7, PIK3CA, PIK3CB, PKLR, PLCG1, PLCG2, PTEN, PTK2, RAF1, RALA, RHO, ROCK1, ROCK2, SHC1, SOS1, SOS2, SRC, TERF2IP, TLN1, TLN2, VASP, WAS, ZYX | 78 | ABL1(1), ACTN1(1), AKT3(1), ARHGEF6(1), BRAF(1), EPHB2(1), GRLF1(1), ITGA4(1), ITGA7(2), ITGA8(2), MAPK1(3), PAK2(1), PAK3(1), PIK3CA(9), PLCG2(1), PTEN(2), PTK2(1), ROCK1(3), ROCK2(2), SOS1(1), SOS2(1) | 6762672 | 37 | 21 | 29 | 9 | 6 | 12 | 10 | 1 | 8 | 0 | 0.000016 | 0.0024 |
5 | HSA04670_LEUKOCYTE_ TRANSENDOTHELIAL_ MIGRATION | Genes involved in Leukocyte transendothelial migration | ACTN1, ACTN2, ACTN3, ACTN4, ARHGAP5, BCAR1, CD99, CDC42, CDH5, CLDN1, CLDN10, CLDN11, CLDN14, CLDN15, CLDN16, CLDN17, CLDN18, CLDN19, CLDN2, CLDN20, CLDN22, CLDN23, CLDN3, CLDN4, CLDN5, CLDN6, CLDN7, CLDN8, CLDN9, CTNNA1, CTNNA2, CTNNA3, CTNNB1, CTNND1, CXCL12, CXCR4, CYBA, CYBB, ESAM, EZR, F11R, GNAI1, GNAI2, GNAI3, GRLF1, ICAM1, ITGA4, ITGAL, ITGAM, ITGB1, ITGB2, ITK, JAM2, JAM3, MAPK11, MAPK12, MAPK13, MAPK14, MLLT4, MMP2, MMP9, MRCL3, MRLC2, MSN, MYL2, MYL5, MYL7, MYL8P, MYL9, MYLC2PL, MYLPF, NCF1, NCF2, NCF4, NOX1, NOX3, OCLN, PECAM1, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R5, PLCG1, PLCG2, PRKCA, PRKCB1, PRKCG, PTK2, PTK2B, PTPN11, PXN, RAC1, RAC2, RAP1A, RAP1B, RAPGEF3, RAPGEF4, RASSF5, RHOA, RHOH, ROCK1, ROCK2, SIPA1, THY1, TXK, VASP, VAV1, VAV2, VAV3, VCAM1, VCL | 109 | ACTN1(1), ACTN3(1), ACTN4(1), CLDN18(1), CTNNA1(1), CTNNA2(2), CTNNA3(2), EZR(1), GNAI2(1), GRLF1(1), ITGA4(1), ITGAM(2), NOX1(1), NOX3(1), PIK3CA(9), PIK3CD(1), PIK3CG(1), PIK3R1(1), PLCG2(1), PRKCA(1), PTK2(1), RHOA(1), ROCK1(3), ROCK2(2) | 6935364 | 38 | 20 | 32 | 14 | 8 | 8 | 15 | 2 | 5 | 0 | 0.000044 | 0.0046 |
6 | NOTCHPATHWAY | Proteolysis and Signaling Pathway of Notch | ADAM17, DLL1, FURIN, NOTCH1, PSEN1, RBPSUH | 5 | ADAM17(1), DLL1(1), NOTCH1(6), PSEN1(2) | 537840 | 10 | 7 | 10 | 2 | 0 | 3 | 5 | 0 | 2 | 0 | 0.000044 | 0.0046 |
7 | SIG_CHEMOTAXIS | Genes related to chemotaxis | ACTR2, ACTR3, AKT1, AKT2, AKT3, ANGPTL2, ARHGAP1, ARHGAP4, ARHGEF11, BTK, CDC42, CFL1, CFL2, GDI1, GDI2, INPPL1, ITPR1, ITPR2, ITPR3, LIMK1, MYLK, MYLK2, P101-PI3K, PAK1, PAK2, PAK3, PAK4, PAK6, PAK7, PDK1, PIK3CA, PIK3CD, PIK3CG, PIK3R1, PITX2, PPP1R13B, PTEN, RACGAP1, RHO, ROCK1, ROCK2, RPS4X, SAG, WASF1, WASL | 44 | AKT3(1), ARHGAP4(2), ARHGEF11(1), BTK(1), GDI1(1), ITPR2(1), LIMK1(1), PAK2(1), PAK3(1), PDK1(1), PIK3CA(9), PIK3CD(1), PIK3CG(1), PIK3R1(1), PTEN(2), ROCK1(3), ROCK2(2), RPS4X(1), SAG(1) | 3887316 | 32 | 17 | 26 | 2 | 6 | 4 | 16 | 1 | 5 | 0 | 0.000071 | 0.0052 |
8 | SA_PTEN_PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. | AKT1, AKT2, AKT3, BPNT1, GRB2, ILK, MAPK1, MAPK3, PDK1, PIK3CA, PIK3CD, PIP3-E, PTEN, PTK2B, RBL2, SHC1, SOS1 | 16 | AKT3(1), MAPK1(3), PDK1(1), PIK3CA(9), PIK3CD(1), PTEN(2), RBL2(1), SOS1(1) | 1114344 | 19 | 11 | 11 | 0 | 5 | 5 | 7 | 0 | 2 | 0 | 0.000072 | 0.0052 |
9 | MTORPATHWAY | Mammalian target of rapamycin (mTOR) senses mitogenic factors and nutrients, including ATP, and induces cell proliferation. | AKT1, EIF3S10, EIF4A1, EIF4A2, EIF4B, EIF4E, EIF4EBP1, EIF4G1, EIF4G2, EIF4G3, FKBP1A, FRAP1, MKNK1, PDK2, PDPK1, PIK3CA, PIK3R1, PPP2CA, PTEN, RPS6, RPS6KB1, TSC1, TSC2 | 21 | EIF4A1(1), EIF4B(1), EIF4G1(3), MKNK1(1), PIK3CA(9), PIK3R1(1), PTEN(2), TSC1(1), TSC2(1) | 1515564 | 20 | 12 | 14 | 3 | 6 | 3 | 9 | 0 | 2 | 0 | 0.000077 | 0.0052 |
10 | ARENRF2PATHWAY | Nrf1 and nrf2 are transcription factors that bind to antioxidant response elements (AREs), promoters of genes involved in oxidative damage control. | CREB1, FOS, FXYD2, JUN, KEAP1, MAFF, MAFG, MAFK, MAPK1, MAPK14, MAPK8, NFE2L2, PRKCA, PRKCB1 | 12 | MAPK1(3), NFE2L2(5), PRKCA(1) | 482076 | 9 | 8 | 6 | 0 | 0 | 7 | 1 | 1 | 0 | 0 | 0.00012 | 0.0074 |
Notes: (Please see notes under significantly mutated gene table)
rank | geneset | description | genes | N_genes | mut_tally | N | n | npat | nsite | nsil | n1 | n2 | n3 | n4 | n5 | n6 | p | q |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | HSA04810_REGULATION_ OF_ACTIN_CYTOSKELETON | Genes involved in regulation of actin cytoskeleton | ABI2, ACTN1, ACTN2, ACTN3, ACTN4, APC, APC2, ARAF, ARHGEF1, ARHGEF12, ARHGEF4, ARHGEF6, ARHGEF7, ARPC1A, ARPC1B, ARPC2, ARPC3, ARPC4, ARPC5, ARPC5L, BAIAP2, BCAR1, BDKRB1, BDKRB2, BRAF, C3orf10, CD14, CDC42, CFL1, CFL2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CRK, CRKL, CSK, CYFIP1, CYFIP2, DIAPH1, DIAPH2, DIAPH3, DOCK1, EGF, EGFR, EZR, F2, F2R, FGD1, FGD3, FGF1, FGF10, FGF11, FGF12, FGF13, FGF14, FGF16, FGF17, FGF18, FGF19, FGF2, FGF20, FGF21, FGF22, FGF23, FGF3, FGF4, FGF5, FGF6, FGF7, FGF8, FGF9, FGFR1, FGFR2, FGFR3, FGFR4, FN1, GIT1, GNA12, GNA13, GNG12, GRLF1, GSN, HRAS, INS, IQGAP1, IQGAP2, IQGAP3, ITGA1, ITGA10, ITGA11, ITGA2, ITGA2B, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8, ITGA9, ITGAD, ITGAE, ITGAL, ITGAM, ITGAV, ITGAX, ITGB1, ITGB2, ITGB3, ITGB4, ITGB5, ITGB6, ITGB7, ITGB8, KRAS, LIMK1, LIMK2, LOC200025, LOC645126, LOC653888, MAP2K1, MAP2K2, MAPK1, MAPK3, MLCK, MOS, MRAS, MRCL3, MRLC2, MSN, MYH10, MYH14, MYH9, MYL2, MYL5, MYL7, MYL8P, MYL9, MYLC2PL, MYLK, MYLK2, MYLPF, NCKAP1, NCKAP1L, NRAS, PAK1, PAK2, PAK3, PAK4, PAK6, PAK7, PDGFA, PDGFB, PDGFRA, PDGFRB, PFN1, PFN2, PFN3, PFN4, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R5, PIP4K2A, PIP4K2B, PIP4K2C, PIP5K1A, PIP5K1B, PIP5K1C, PIP5K3, PPP1CA, PPP1CB, PPP1CC, PPP1R12A, PPP1R12B, PTK2, PXN, RAC1, RAC2, RAC3, RAF1, RDX, RHOA, ROCK1, ROCK2, RRAS, RRAS2, SCIN, SLC9A1, SOS1, SOS2, SSH1, SSH2, SSH3, TIAM1, TIAM2, TMSB4X, TMSB4Y, TMSL3, VAV1, VAV2, VAV3, VCL, WAS, WASF1, WASF2, WASL | 202 | ACTN1(1), ACTN3(1), ACTN4(1), APC(3), ARHGEF6(1), ARPC5(1), BRAF(1), CYFIP1(1), DIAPH3(2), EGFR(1), EZR(1), F2R(1), FGF17(1), FGF2(1), FGF9(1), FN1(2), GNA13(1), GRLF1(1), ITGA4(1), ITGA7(2), ITGA8(2), ITGAE(1), ITGAM(2), ITGAV(1), KRAS(1), LIMK1(1), MAPK1(3), MYH10(2), MYH14(2), MYH9(5), NCKAP1(1), NCKAP1L(1), PAK2(1), PAK3(1), PIK3CD(1), PIK3CG(1), PIK3R1(1), PIP5K1A(1), PPP1CB(1), PPP1R12A(3), PTK2(1), RHOA(1), ROCK1(3), ROCK2(2), SLC9A1(2), SOS1(1), SOS2(1), SSH2(1), SSH3(1), TIAM1(1), WASF2(1) | 15268428 | 72 | 27 | 70 | 28 | 4 | 29 | 19 | 5 | 15 | 0 | 1.67e-06 | 0.00052 |
2 | HSA04510_FOCAL_ADHESION | Genes involved in focal adhesion | ACTB, ACTG1, ACTN1, ACTN2, ACTN3, ACTN4, AKT1, AKT2, AKT3, ARHGAP5, BAD, BCAR1, BCL2, BIRC2, BIRC3, BIRC4, BRAF, CAPN2, CAV1, CAV2, CAV3, CCND1, CCND2, CCND3, CDC42, CHAD, COL11A1, COL11A2, COL1A1, COL1A2, COL2A1, COL3A1, COL4A1, COL4A2, COL4A4, COL4A6, COL5A1, COL5A2, COL5A3, COL6A1, COL6A2, COL6A3, COL6A6, COMP, CRK, CRKL, CTNNB1, DIAPH1, DOCK1, EGF, EGFR, ELK1, ERBB2, FARP2, FIGF, FLNA, FLNB, FLNC, FLT1, FN1, FYN, GRB2, GRLF1, GSK3B, HGF, HRAS, IBSP, IGF1, IGF1R, ILK, ITGA1, ITGA10, ITGA11, ITGA2, ITGA2B, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8, ITGA9, ITGAV, ITGB1, ITGB3, ITGB4, ITGB5, ITGB6, ITGB7, ITGB8, JUN, KDR, LAMA1, LAMA2, LAMA3, LAMA4, LAMA5, LAMB1, LAMB2, LAMB3, LAMB4, LAMC1, LAMC2, LAMC3, LOC653852, MAP2K1, MAPK1, MAPK10, MAPK3, MAPK8, MAPK9, MET, MLCK, MRCL3, MRLC2, MYL2, MYL5, MYL7, MYL8P, MYL9, MYLC2PL, MYLK, MYLK2, MYLPF, PAK1, PAK2, PAK3, PAK4, PAK6, PAK7, PARVA, PARVB, PARVG, PDGFA, PDGFB, PDGFC, PDGFD, PDGFRA, PDGFRB, PDPK1, PGF, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R5, PIP5K1C, PPP1CA, PPP1CB, PPP1CC, PPP1R12A, PRKCA, PRKCB1, PRKCG, PTEN, PTK2, PXN, RAC1, RAC2, RAC3, RAF1, RAP1A, RAP1B, RAPGEF1, RELN, RHOA, ROCK1, ROCK2, SHC1, SHC2, SHC3, SHC4, SOS1, SOS2, SPP1, SRC, THBS1, THBS2, THBS3, THBS4, TLN1, TLN2, TNC, TNN, TNR, TNXB, VASP, VAV1, VAV2, VAV3, VCL, VEGFA, VEGFB, VEGFC, VTN, VWF, ZYX | 191 | ACTN1(1), ACTN3(1), ACTN4(1), AKT3(1), BRAF(1), COL11A2(4), COL1A2(2), COL3A1(1), COL4A1(1), COL5A1(1), COL5A3(2), COL6A3(2), COMP(1), EGFR(1), ERBB2(1), FLNA(2), FLNC(1), FN1(2), GRLF1(1), ITGA4(1), ITGA7(2), ITGA8(2), ITGAV(1), LAMA1(2), LAMA2(1), LAMA4(1), LAMA5(1), LAMB1(1), LAMB2(1), LAMB3(1), MAPK1(3), PAK2(1), PAK3(1), PDGFC(1), PIK3CD(1), PIK3CG(1), PIK3R1(1), PPP1CB(1), PPP1R12A(3), PRKCA(1), PTEN(2), PTK2(1), RELN(2), RHOA(1), ROCK1(3), ROCK2(2), SOS1(1), SOS2(1), TNC(2), TNXB(2), VWF(1) | 20443356 | 73 | 27 | 71 | 18 | 2 | 27 | 28 | 3 | 13 | 0 | 1.69e-06 | 0.00052 |
3 | HSA04320_DORSO_VENTRAL_ AXIS_FORMATION | Genes involved in dorso-ventral axis formation | BRAF, CPEB1, EGFR, ERBB2, ERBB4, ETS1, ETS2, ETV6, ETV7, FMN2, GRB2, KRAS, MAP2K1, MAPK1, MAPK3, NOTCH1, NOTCH2, NOTCH3, NOTCH4, PIWIL1, PIWIL2, PIWIL3, PIWIL4, RAF1, SOS1, SOS2, SPIRE1, SPIRE2 | 28 | BRAF(1), EGFR(1), ERBB2(1), FMN2(1), KRAS(1), MAPK1(3), NOTCH1(6), NOTCH2(2), NOTCH4(1), PIWIL1(2), PIWIL3(1), PIWIL4(2), SOS1(1), SOS2(1) | 2917044 | 24 | 17 | 22 | 3 | 2 | 8 | 8 | 1 | 5 | 0 | 0.000014 | 0.0028 |
4 | NOTCHPATHWAY | Proteolysis and Signaling Pathway of Notch | ADAM17, DLL1, FURIN, NOTCH1, PSEN1, RBPSUH | 5 | ADAM17(1), DLL1(1), NOTCH1(6), PSEN1(2) | 537840 | 10 | 7 | 10 | 2 | 0 | 3 | 5 | 0 | 2 | 0 | 0.000044 | 0.0068 |
5 | HSA05130_PATHOGENIC_ ESCHERICHIA_COLI_ INFECTION_EHEC | Genes involved in pathogenic Escherichia coli infection - EHEC | ABL1, ACTB, ACTG1, ARHGEF2, ARPC5, ARPC5L, CD14, CDC42, CDH1, CLDN1, CTNNB1, CTTN, EZR, FYN, HCLS1, ITGB1, KRT18, LOC643224, LOC654264, LY96, NCK1, NCK2, NCL, OCLN, PRKCA, RHOA, ROCK1, ROCK2, TLR4, TLR5, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBA8, TUBAL3, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB2C, TUBB3, TUBB4, TUBB4Q, TUBB6, TUBB8, WAS, WASL, YWHAQ, YWHAZ | 51 | ABL1(1), ARHGEF2(2), ARPC5(1), CTTN(1), EZR(1), LY96(1), PRKCA(1), RHOA(1), ROCK1(3), ROCK2(2), TUBA1C(1), TUBA3C(1), TUBA8(1), TUBB4(1), YWHAZ(1) | 2897604 | 19 | 13 | 19 | 8 | 2 | 3 | 8 | 1 | 5 | 0 | 0.00015 | 0.015 |
6 | HSA05131_PATHOGENIC_ ESCHERICHIA_COLI_ INFECTION_EPEC | Genes involved in pathogenic Escherichia coli infection - EPEC | ABL1, ACTB, ACTG1, ARHGEF2, ARPC5, ARPC5L, CD14, CDC42, CDH1, CLDN1, CTNNB1, CTTN, EZR, FYN, HCLS1, ITGB1, KRT18, LOC643224, LOC654264, LY96, NCK1, NCK2, NCL, OCLN, PRKCA, RHOA, ROCK1, ROCK2, TLR4, TLR5, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBA8, TUBAL3, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB2C, TUBB3, TUBB4, TUBB4Q, TUBB6, TUBB8, WAS, WASL, YWHAQ, YWHAZ | 51 | ABL1(1), ARHGEF2(2), ARPC5(1), CTTN(1), EZR(1), LY96(1), PRKCA(1), RHOA(1), ROCK1(3), ROCK2(2), TUBA1C(1), TUBA3C(1), TUBA8(1), TUBB4(1), YWHAZ(1) | 2897604 | 19 | 13 | 19 | 8 | 2 | 3 | 8 | 1 | 5 | 0 | 0.00015 | 0.015 |
7 | HSA04530_TIGHT_JUNCTION | Genes involved in tight junction | ACTB, ACTG1, ACTN1, ACTN2, ACTN3, ACTN4, AKT1, AKT2, AKT3, AMOTL1, ASH1L, CASK, CDC42, CDK4, CGN, CLDN1, CLDN10, CLDN11, CLDN14, CLDN15, CLDN16, CLDN17, CLDN18, CLDN19, CLDN2, CLDN20, CLDN22, CLDN23, CLDN3, CLDN4, CLDN5, CLDN6, CLDN7, CLDN8, CLDN9, CRB3, CSDA, CSNK2A1, CSNK2A2, CSNK2B, CTNNA1, CTNNA2, CTNNA3, CTNNB1, CTTN, EPB41, EPB41L1, EPB41L2, EPB41L3, EXOC3, EXOC4, F11R, GNAI1, GNAI2, GNAI3, HCLS1, HRAS, IGSF5, INADL, JAM2, JAM3, KRAS, LLGL1, LLGL2, MAGI1, MAGI2, MAGI3, MLLT4, MPDZ, MPP5, MRAS, MRCL3, MRLC2, MYH1, MYH10, MYH11, MYH13, MYH14, MYH15, MYH2, MYH3, MYH4, MYH6, MYH7, MYH7B, MYH8, MYH9, MYL2, MYL5, MYL7, MYL8P, MYL9, MYLC2PL, MYLPF, NRAS, OCLN, PARD3, PARD6A, PARD6B, PARD6G, PPM1J, PPP2CA, PPP2CB, PPP2R1A, PPP2R1B, PPP2R2A, PPP2R2B, PPP2R2C, PPP2R3A, PPP2R3B, PPP2R4, PRKCA, PRKCB1, PRKCD, PRKCE, PRKCG, PRKCH, PRKCI, PRKCQ, PRKCZ, PTEN, RAB13, RAB3B, RHOA, RRAS, RRAS2, SPTAN1, SRC, SYMPK, TJAP1, TJP1, TJP2, TJP3, VAPA, YES1, ZAK | 130 | ACTN1(1), ACTN3(1), ACTN4(1), AKT3(1), AMOTL1(1), ASH1L(2), CGN(1), CLDN18(1), CTNNA1(1), CTNNA2(2), CTNNA3(2), CTTN(1), EPB41(1), GNAI2(1), KRAS(1), LLGL2(1), MAGI1(1), MAGI2(1), MYH1(3), MYH10(2), MYH11(1), MYH13(1), MYH14(2), MYH15(2), MYH2(1), MYH3(1), MYH6(3), MYH7(1), MYH7B(1), MYH8(3), MYH9(5), PARD3(1), PPM1J(1), PPP2R1A(1), PPP2R3A(1), PRKCA(1), PTEN(2), RHOA(1), SPTAN1(2) | 10681812 | 57 | 23 | 57 | 18 | 4 | 17 | 21 | 5 | 10 | 0 | 0.00040 | 0.032 |
8 | PS1PATHWAY | Presenilin is required for gamma-secretase activity to activate Notch signaling; presenilin also inhibits beta-catenin in the Wnt/Frizzled pathway. | ADAM17, APC, AXIN1, BTRC, CTNNB1, DLL1, DVL1, FZD1, GSK3B, NOTCH1, PSEN1, RBPSUH, TCF1, WNT1 | 12 | ADAM17(1), APC(3), DLL1(1), NOTCH1(6), PSEN1(2) | 1174716 | 13 | 9 | 13 | 2 | 0 | 4 | 6 | 1 | 2 | 0 | 0.00042 | 0.032 |
9 | ST_TYPE_I_INTERFERON_ PATHWAY | Type I interferon is an antiviral cytokine that induces a JAK-STAT type pathway leading to ISGF3 activation and a cellular antiviral response. | IFNAR1, IFNB1, ISGF3G, JAK1, PTPRU, REG1A, STAT1, STAT2, TYK2 | 8 | IFNAR1(1), REG1A(1), STAT1(2), TYK2(3) | 684288 | 7 | 7 | 7 | 1 | 0 | 3 | 3 | 1 | 0 | 0 | 0.00052 | 0.035 |
10 | ST_INTEGRIN_SIGNALING_ PATHWAY | Integrins are transmembrane receptors that mediate cell growth, survival, and migration by binding to ligands in the extracellular matrix. | ABL1, ACK1, ACTN1, ACTR2, ACTR3, AKT1, AKT2, AKT3, ANGPTL2, ARHGEF6, ARHGEF7, BCAR1, BRAF, CAV1, CDC42, CDKN2A, CRK, CSE1L, DDEF1, DOCK1, EPHB2, FYN, GRAF, GRB2, GRB7, GRF2, GRLF1, ILK, ITGA1, ITGA10, ITGA11, ITGA2, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8, ITGA9, ITGB3BP, MAP2K4, MAP2K7, MAP3K11, MAPK1, MAPK10, MAPK8, MAPK8IP1, MAPK8IP2, MAPK8IP3, MAPK9, MRAS, MYLK, MYLK2, P4HB, PAK1, PAK2, PAK3, PAK4, PAK6, PAK7, PIK3CA, PIK3CB, PKLR, PLCG1, PLCG2, PTEN, PTK2, RAF1, RALA, RHO, ROCK1, ROCK2, SHC1, SOS1, SOS2, SRC, TERF2IP, TLN1, TLN2, VASP, WAS, ZYX | 77 | ABL1(1), ACTN1(1), AKT3(1), ARHGEF6(1), BRAF(1), EPHB2(1), GRLF1(1), ITGA4(1), ITGA7(2), ITGA8(2), MAPK1(3), PAK2(1), PAK3(1), PLCG2(1), PTEN(2), PTK2(1), ROCK1(3), ROCK2(2), SOS1(1), SOS2(1) | 6644340 | 28 | 18 | 26 | 9 | 1 | 12 | 6 | 1 | 8 | 0 | 0.00057 | 0.035 |
Notes: (Please see notes under significantly mutated gene table)